Sabha MacManus
Associate General Counsel, UK Serious Fraud Office (London, England)
[email protected] | 973-642-8382 or 973-761-9000 ext. 8382
PROGRAM SCHEDULED for October 9, 2026 | In-Person
PROGRAM SCHEDULED for June 11, 2027 | Virtual
All times are in Eastern Standard Time.
8:30 - 9:00
Registration & Breakfast
9:00 - 9:05
Welcome & Format Review
9:05 - 10:05
International Anti-Corruption Enforcement
Sabha MacManus
Associate General Counsel, UK Serious Fraud Office (London, England)
Albert Stieglitz
Mayer Brown (Washington, DC)
Moderator: Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
10:05 - 10:20
Break
10:20 - 11:20
Compliance-Specific Takeaways in Terms of Enforcement Priorities
Gary Giampetruzzi
Partner, Litigation Department, Paul Hastings LLP
Terra Buckley
Chief Compliance & Ethics Officer, Bristol Myers Squibb
Patrick Gibson
Lead Compliance Counsel, Investigations, and Operations, Otsuka
Garrett Schuman
Senior Counsel, Johnson & Johnson
11:25 - 12:25
Third Party Arrangements
Matthew Sullivan
Partner, Disputes, Hogan Lovells Cadwalader
Christina Hud
Senior Compliance Counsel, Global Investigations, Pfizer
Patricia Petit
Sr. Director, Compliance Officer for the Americas and Global Business Partner, Olympus Corporation of the Americas
12:25 - 1:15
Lunch Break
1:15 - 2:15
Case Study: Leading Positive Change Under a Deferred Prosecution Agreement Monitorship
Christine Gordon
Chief Compliance Officer, Olympus Corporation of the Americas
Learn more about Christine Gordon
Christina Hud
Senior Compliance Counsel, Global Investigations, Pfizer
Gregory Paw
Partner, Freeh, Sporkin & Sullivan
David Walk
Deputy Chief, Criminal Division, U.S. Attorney’s Office, District of New Jersey
2:20 - 3:45
Practical Application Case Study
Wendy Tsuei
Founder, ComplianSure
3:45
Program Close
